ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
39,927.92
0.15%
Gold vs US Dollar
2,409.655
1.32%
Brent Oil
83.535
0.40%
Bitcoin
67,049.10
2.77%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Okyo Pharma Limited (OKYO) Share Price

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Okyo Pharma Limited LSE:OKYO London Stock Exchange Ordinary Share GG00BD3FV870 ORD NPV
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 91.00 1.20 1.60 0.00 0.00  0.00 00:00:00   
 Type  Size  Price  Time  Units 
   0.00  
 
Recent News
DateTimeSource
HeadlineMore OKYO News
08/05/202412:00UKREGOKYO Pharma Announces Participation in May 2024 Investor Conferences
30/04/202412:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
09/04/202400:00UKREGOKYO Pharma to Reschedule Key Opinion Leader Event in Dry Eye Disease to May 2024
02/04/202412:00UKREGOKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at Eyecelerator 2024, a Partner Meeting of the American Society for Cataract and Refractive Surgery
22/03/202411:00UKREGOKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
21/03/202411:00UKREGOKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial
20/03/202411:00UKREGOKYO Pharma to Release New and Comprehensive Data from Phase 2 Dry Eye Disease Trial and Host Key Opinion Leader Event
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
09/01/202413:18PBBOKYO Pharma PLC694
17/04/201905:44PBB(OKYO) OKYO Pharma Says Data Shows Potential Of Its Dry Eye Treatment7
17/04/201905:44PBBOKYO PHARMA (OKYO)15
Data Downloads for OKYO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Okyo Pharma Limited
Get quick technical analysis for Okyo Pharma Limited.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.
Related Shares
Bhp (BHP), Rio Tinto (RIO), Hamak Gold (HAMA), Pembridge Resources (PERE)


Loading Follow Feed...

Latest Okyo Pharma Limited Articles